Successful administration of second dose of BNT162b2 COVID-19 vaccine in two patients with potential anaphylaxis to first dose. | Allergy;77(1): 337-338, 2022 01. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

WHO COVID-19 Research Database

News/Update/Help

Advanced Search

The WHO Covid-19 Research Database is a resource created in response to the Public Health Emergency of International Concern (PHEIC). Its content remains searchable and spans the time period March 2020 to June 2023. Since June 2023, manual updates to the database have been discontinued.

Successful administration of second dose of BNT162b2 COVID-19 vaccine in two patients with potential anaphylaxis to first dose.

Cahill, Julia A; Kan, Manstein.

Cahill JA; Fraser Health Authority, Langley, BC, Canada.
Kan M; Fraser Allergy, Langley, BC, Canada.

Allergy ; 77(1): 337-338, 2022 01.

Article in English | MEDLINE | ID: covidwho-1583698

Subject(s)

Anaphylaxis; COVID-19; Anaphylaxis/diagnosis; Anaphylaxis/etiology; BNT162 Vaccine; COVID-19 Vaccines; Humans; SARS-CoV-2

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 / Anaphylaxis Type of study: Diagnostic study Topics: Vaccines Limits: Humans Language: English Journal: Allergy Year: 2022 Document Type: Article Affiliation country: All.14996

Similar

MEDLINE

LILACS

LIS

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 / Anaphylaxis Type of study: Diagnostic study Topics: Vaccines Limits: Humans Language: English Journal: Allergy Year: 2022 Document Type: Article Affiliation country: All.14996